Zenotech Laboratories Share Price

44.950.87 (1.97%)

BSE

Closed
As On:
As On: 15 Jun, 2026, 03:49 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-44.95
Previous Day	-44.08

Zenotech Lab Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Zenotech Lab Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	10.48	13.28	11.94	10.23	12.62
Total Income Growth (%)	-21.09	11.24	16.66	-18.95	8.70
Total Expenses	11.41	10.69	10.68	8.95	9.44
Total Expenses Growth (%)	6.78	0.09	19.25	-5.11	10.97
EBIT	-0.94	2.59	1.26	1.28	3.19
EBIT Growth (%)	-136.13	105.80	-1.46	-59.93	2.49
Profit after Tax (PAT)	-3.15	1.93	-0.84	0.99	1.23
PAT Growth (%)	-263.63	-	-184.53	-19.53	-27.35
EBIT Margin (%)	-8.93	19.50	10.54	12.48	25.24
Net Profit Margin (%)	-30.07	14.50	-7.01	9.67	9.74
Basic EPS (₹)	-0.52	0.32	-0.14	0.16	0.20

Annual	FY 2010	FY 2009	FY 2008	FY 2007
Total Revenue	8.34	11.36	10.32	21.96
Total Revenue Growth (%)	-26.57	10.14	-53.02	76.22
Total Expenses	20.89	28.88	23.86	23.05
Total Expenses Growth (%)	-27.67	21.03	3.53	45.24
Profit after Tax (PAT)	-12.52	-17.56	-16.07	1.65
PAT Growth (%)	-	-	-1,076.67	-
Operating Profit Margin (%)	-165.55	-251.50	-134.39	8.39
Net Profit Margin (%)	-189.76	-284.07	-196.99	13.00
Basic EPS (₹)	-3.64	-5.10	-4.68	0.57

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	45.92	44.60	41.84	43.51	37.19
Total Revenue Growth (%)	2.98	6.59	-3.84	16.97	62.75
Total Expenses	41.54	35.83	30.70	29.01	27.29
Total Expenses Growth (%)	15.94	16.72	5.83	6.27	13.40
Profit after Tax (PAT)	-1.07	5.61	8.30	11.59	22.18
PAT Growth (%)	-119.10	-32.36	-28.37	-47.76	-
Operating Profit Margin (%)	10.05	20.37	27.28	34.44	30.40
Net Profit Margin (%)	-2.45	13.03	20.32	27.30	60.64
Basic EPS (₹)	-0.18	0.92	1.36	1.90	3.63

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 21.09%, which is lowest in the last 3 years. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 35.6% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

View Details

Balance Sheet

Annual	FY 2010	FY 2009	FY 2008	FY 2007
Total Assets	110.57	130.82	153.07	106.32
Total Assets Growth (%)	-15.48	-14.54	43.97	43.74
Total Liabilities	14.09	22.20	26.69	52.15
Total Liabilities Growth (%)	-36.53	-16.82	-48.82	25.68
Total Equity	96.45	108.61	126.37	54.16
Total Equity Growth (%)	-11.20	-14.05	133.32	66.82
Current Ratio (x)	6.42	4.14	5.77	1.40
Total Debt to Equity (x)	0.11	0.16	0.15	0.63
Contingent Liabilities	-	0.21	1.55	2.60

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	111.15	111.03	106.21	100.87	94.08
Total Assets Growth (%)	0.11	4.54	5.29	7.22	9.60
Total Liabilities	16.03	14.90	15.66	18.60	23.44
Total Liabilities Growth (%)	7.58	-4.85	-15.81	-20.65	-37.39
Total Equity	95.12	96.13	90.54	82.27	70.64
Total Equity Growth (%)	-1.05	6.17	10.05	16.46	45.92
Current Ratio (x)	3.40	2.86	1.93	0.98	0.47
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.08
Contingent Liabilities	0.00	16.20	15.06	20.88	11.27

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2010	FY 2009	FY 2008	FY 2007
Net Cash flow from Operating Activities	-9.85	-15.55	-2.98	-6.98
Net Cash used in Investing Activities	29.11	20.18	-67.30	-15.29
Net Cash flow from Financing Activities	-8.34	-3.81	70.05	22.20
Net Cash Flow	10.91	0.82	-0.23	-0.07
Closing Cash & Cash Equivalent	12.34	1.42	0.60	2.33
Closing Cash & Cash Equivalent Growth (%)	766.50	135.90	-74.07	-2.93
Total Debt/ CFO (x)	-1.03	-1.09	-6.36	-4.87

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	10.20	9.49	11.82	20.66	17.67
Net Cash used in Investing Activities	-6.49	15.29	-21.15	-5.82	-1.84
Net Cash flow from Financing Activities	-	-	-	-6.11	-15.87
Net Cash Flow	3.71	24.76	-9.33	8.73	-0.04
Closing Cash & Cash Equivalent	30.29	26.58	1.82	11.14	2.41
Closing Cash & Cash Equivalent Growth (%)	13.98	1,363.63	-83.70	361.42	-1.75
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.34

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2010	FY 2009	FY 2008	FY 2007
Return on Equity (%)	-12.98	-16.17	-12.71	3.03
Return on Capital Employed (%)	-10.25	-12.89	-7.80	1.17
Return on Assets (%)	-11.32	-13.42	-10.50	1.54
Interest Coverage Ratio (x)	-6.75	-7.90	-4.25	0.49
Asset Turnover Ratio (x)	5.96	4.72	5.33	11.90
Price to Earnings (x)	-31.06	-17.01	-20.08	175.44
Price to Book (x)	4.03	2.75	2.55	5.31
EV/EBITDA (x)	-49.90	-22.66	-35.41	109.81
EBITDA Margin (%)	-116.18	-201.77	-97.25	22.98

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-1.12	5.83	9.16	14.08	31.39
Return on Capital Employed (%)	4.42	8.90	12.02	17.34	14.15
Return on Assets (%)	-0.96	5.05	7.81	11.48	23.57
Interest Coverage Ratio (x)	0.00	0.00	0.00	194.18	14.89
Asset Turnover Ratio (x)	0.39	0.40	0.39	0.44	0.41
Price to Earnings (x)	-196.08	56.50	43.67	24.81	13.87
Price to Book (x)	2.20	3.30	3.98	3.49	4.35
EV/EBITDA (x)	15.56	18.45	18.71	12.67	17.18
EBITDA Margin (%)	26.36	36.53	44.63	51.35	49.47

Insights

Passing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Standalone Financials)

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Zenotech Lab	-255.88	2.84	-12.98	-10.25	-11.32	1.80	-165.55	-189.76	-3.64	6.42	0.11	-1.03
Zim Laboratories	104.93	2.07	1.97	6.13	1.08	-1.59	5.71	1.55	1.19	1.45	0.42	2.48
SMS Lifesciences Ind	23.68	1.79	8.10	10.61	3.80	1.79	9.47	5.33	57.26	1.04	0.51	2.92
Medico Remedies	26.56	4.61	17.37	26.22	8.54	13.57	9.62	6.35	1.58	1.66	0.25	3.21
Gennex Labs	10.78	1.13	9.42	9.93	6.01	37.10	15.88	12.14	0.76	3.66	0.16	-0.56
Add More

Annual Ratios (%)

Choose from Peers

Lyka Labs
Everest Org
Nectar Lifesc
Sanjivani paranteral
S S Organic

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Zenotech Lab Stock Performance	1.97	-0.29	-3.42	-3.04	-29.02	-13.76	2.39
Zim Laboratories Stock Performance	1.37	14.88	36.62	61.29	29.42	13.30	281.67
SMS Lifesciences Ind Stock Performance	0.39	-17.32	1.20	0.00	5.53	146.46	123.03
Medico Remedies Stock Performance	-2.14	-3.58	2.79	-8.80	-23.13	-49.34	0.00
Gennex Labs Stock Performance	1.98	13.56	1.12	-7.61	-15.76	69.28	67.44
Add More

Category	No. of Shares	Percentage
Promoters	4,20,14,578	68.84 %
Pledge	0	0.00 %
Others	1,90,15,990	31.15 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	68.84	68.84	68.84	68.84
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	31.15	31.15	31.15	31.15

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
Apr 23, 2026
General Meeting
-
Feb 09, 2026
Board Meeting
Quarterly Results
Jan 16, 2026

Board Meetings

Announced on	Meeting on
Apr 23, 2026	Apr 29, 2026
Audited Results
Jan 16, 2026	Jan 23, 2026
Quarterly Results
Oct 23, 2025	Oct 31, 2025
Quarterly Results
Jul 21, 2025	Jul 28, 2025
Quarterly Results
Apr 21, 2025	Apr 25, 2025
Audited Results

Dividends
No Data Available
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
May 21, 2016 Jun 01, 2017
Rights ratio: 17 share for every 22 held at a price of Rs 45.0
AGM/EGM Meetings
Announced on Meeting on
Feb 09, 2026 Mar 13, 2026
-
Aug 29, 2025 Sep 26, 2025
-
Feb 12, 2025 Mar 16, 2025
-
Jul 26, 2024 Sep 27, 2024
-
Aug 01, 2023 Sep 29, 2023
-

Announced on	Ex-Date
May 21, 2016	Jun 01, 2017
Rights ratio: 17 share for every 22 held at a price of Rs 45.0

Announced on	Meeting on
Feb 09, 2026	Mar 13, 2026
-
Aug 29, 2025	Sep 26, 2025
-
Feb 12, 2025	Mar 16, 2025
-
Jul 26, 2024	Sep 27, 2024
-
Aug 01, 2023	Sep 29, 2023
-

About Zenotech Lab

Zenotech Laboratories Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 274.33 Crore) operating in Pharmaceuticals sector.

Zenotech Laboratories Ltd. key Products/Revenue Segments include Sale of services and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 10.48 Crore, down 21.09 % from last quarter Total Income of Rs 13.28 Crore and down 17.01 % from last year same quarter Total Income of Rs 12.62 Crore. Company has reported net profit after tax of Rs -3.15 Crore in latest quarter.

The company’s top management includes Dr.Sachin Laxmanappa Gavandare, Dr.Azadar Husain Asghar Mehdi Khan, Mr.Jignesh Anantray Goradia, Mr.Rakeshchandra Jagdishprasad Sinha, Mr.Chintan Jitendra Shah, Mr.Jagruti Prashant Sheth, Mr.Premal Hemant Gandhi, Mr.Poly K V, Mr.Abdul Gafoor Mohammad. Company has PKF Sridhar & Santhanam�LLP as its auditors. As on 31-03-2026, the company has a total of 6.10 Crore shares outstanding.

Zenotech Lab Share Price Today is Rs. 44.95. On previous day, the Zenotech Lab Share Price (NSE) closed at Rs. 44.08, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 68.84% of the stake in Zenotech Lab shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Zenotech Lab stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Zenotech Lab shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Zenotech Lab stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Zenotech Lab Dividend: Ever since 1989, Zenotech Lab dividends has been paid out around 0 times. As on 15 Jun, 2026, 03:49 PM IST, The overall dividend yield for Zenotech Lab stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -0.18.

Zenotech Lab Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 11.49 Cr. of sales and 19.66% of quarterly net loss, there have been multiple ups and downs in the Zenotech Lab stock prices in the past few weeks. For example, Zenotech Lab stock price on 8th of June 2026 was around Rs. 44.5. Zenotech Lab share price now stands at an average of Rs. 44.95. Judging by last week's performance, stock is in down trend.

Zenotech Lab has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Zenotech Lab share.

Historical Prices and Performance:
Zenotech Lab, incorporated in 1989 is a Small Cap company (with a market cap of Rs. 274.33) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Zenotech Lab stock was -1.12%, 5.83%, 9.16%, 14.08% and 31.39% respectively.
The Zenotech Lab share gave a 3 year return of -12.0% as compared to Nifty 50 which gave a return of 27.64%.
Zenotech Lab announced 0.0% final dividend on null.

Key Metrics:
PE Ratio of Zenotech Lab is -250.48
Prices/Sales Ratio of Zenotech Lab is 58.92
Price/Book Ratio of Zenotech Lab is 2.78

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at -250.48 and 2.78 respectively.

Leadership of Zenotech Lab :
Abdul Gafoor Mohammad is Co. Secretary & Compl. Officer
Poly K V is Chief Financial Officer
Sachin Laxmanappa Gavandare is Chief Executive Officer
Azadar Husain Asghar Mehdi Khan is Non Executive Director
Jignesh Anantray Goradia is Non Executive Director
Rakeshchandra Jagdishprasad Sinha is Non Executive Director
Chintan Jitendra Shah is Independent Director
Jagruti Prashant Sheth is Independent Director
Premal Hemant Gandhi is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

Survey No. 250-252,Turkapally Village,Shameerpet Mandal,Hyderabad, Telangana - 500078

Contact

info@zenotech.co.in

http://www.zenotechlab.com

PE Ratio(x)	-255.88
EPS - TTM(₹)	-0.18
MCap(₹ Cr.)	274.33
MCap Rank	111
PB Ratio(x)	2.78
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	67.00
52W Low(₹)	33.55
MCap/Sales	58.92
Beta(1 Month)	2.10
BV/Share(₹)	15.81

1 Day	1.97%
1 Month	-0.11%
3 Months	15.49%
1 Year	-27.56%
3 Years	-18.33%
5 Years	11.4%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Zenotech Laboratories Share Price

Key Metrics

Zenotech Lab share price insights

Zenotech Lab Share Price Returns

Zenotech Lab Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Zenotech Lab Top Searches

Corporate Actions

About Zenotech Lab

Executive Leadership

Auditors

FAQs about Zenotech Lab share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News